Eggenfelden, Germany

Julia Festag

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Secarna Pharmaceuticals Gmbh & Co. Kg. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia Festag. Retrieved from https://idiyas.com/inventor/julia-festag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia Festag: Innovator in Antisense Oligonucleotide Technology

Introduction

Julia Festag is a prominent inventor based in Eggenfelden, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. Her innovative work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Julia Festag holds a patent for a "Modified antisense oligonucleotide for inhibition of FoxP3 expression." This invention represents a crucial advancement in the modulation of immune responses, which could lead to new treatments for autoimmune diseases and cancer.

Career Highlights

Julia is currently employed at Secarna Pharmaceuticals GmbH & Co. KG, where she continues to push the boundaries of scientific research and innovation. Her dedication to her work has established her as a key figure in her field.

Collaborations

Julia has collaborated with notable colleagues, including Richard Klar and Frank Jaschinski. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Julia Festag's contributions to the field of biotechnology through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…